Showing results (71-80 of 254) with videos related to
Sort By:
Pageof 26
The International Journal of Biostatistics|July 29, 2024
Comments on "sensitivity of estimands in clinical trials with imperfect compliance" by Chen and HeitjanStuart G Baker, Karen S LindemanAnnals of Internal Medicine|January 13, 2016
The Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation ModelJeanette Birnbaum, Vijayakrishna K Gadi, Elan Markowitz, et al.JCO Oncology Practice|October 18, 2023
Multicancer Early Detection Tests: An Overview of Early Results From Prospective Clinical Studies and Opportunities for OncologistsCarl Post, Theodore P Braun, Ruth Etzioni, et al.Urology|February 9, 2002
Prostate-specific antigen testing in black and white men: an analysis of medicare claims from 1991-1998Ruth Etzioni, Kristin M Berry, Julie M Legler, et al.Medical Decision Making : an International Journal of the Society for Medical Decision Making|June 1, 2017
A Framework for Treatment Decision Making at Prostate Cancer RecurrenceJane M Lange, Bruce J Trock, Roman Gulati, et al.Medical Care|August 21, 2002
Estimating health care costs related to cancer treatment from SEER-Medicare dataMartin L Brown, Gerald F Riley, Nicki Schussler, et al.Journal of Surgical Oncology|February 15, 2017
Demographic changes in breast cancer incidence, stage at diagnosis and age associated with population-based mammographic screeningFrancys C Verdial, Ruth Etzioni, Catherine Duggan, et al.Cancer|November 2, 2022
Modeling the impact of novel systemic treatments on lung cancer screening benefitsKemal Caglar Gogebakan, Jane Lange, Christopher G Slatore, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 20, 2024
Projecting the Impact of Multi-Cancer Early Detection on Late-Stage Incidence Using Multi-State Disease ModelingJane M Lange, Kemal Caglar Gogebakan, Roman Gulati, et al.Statistical Methods in Medical Research|December 14, 2004
The use of modeling to understand the impact of screening on U.S. mortality: examples from mammography and PSA testingEric J Feuer, Ruth Etzioni, Kathleen A Cronin, et al.Pageof 26